Johnson & Johnson is in talks to buy Swiss medical device maker Synthes for $20 billion, according to a report on the Wall Street Journal website, citing people familiar with the matter.
52695
J&J in talks to buy Synthes for $20 billion:
80180
Novartis buys rights to new antibiotic
97892
Vale to invest at least $20 billion in 2011: source
17409
Goldman Sachs upgrades IBM (IBM) to Buy
145594
IBM in talks to buy Sun Microsystems - sources
98888
S&P Capital IQ acquires QuantHouse --
76804
Pfizer in talks to acquire rival Wyeth
91538
Sprint proposes $2.1 billion buyout of Clearwire
151944
Jp Morgan upgrades Johnson & Johnson to Overweight;
41423
Dainippon Sumitomo Pharma to buy US bio-venture
125203
Texas Instruments buying National Semiconductor
74916
Mckesson to buy PSS World Medical for $2.1 billion
161663
Onex close to a deal to buy KraussMaffei
95911
Sanofi-Aventis to acquire Genzyme?
170411
Goldman Sachs upgrades Novo Nordisk (nvo) to Buy
36882
Fleetwood Enterprises offering of 12 million shares priced at $3.40 a share
52329
Private equity firm Apollo in talks to buy Pactiv Corp: